Actuate Therapeutics Inc

ACTU | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.86

-$0.05 (-5.21%)

Sep 22, 2026, 11:50 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Cash & Equivalents	13.16M	8.64M	2.96M	20.45M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	392.49K	110.55K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	484K	0	36.91K	33.75K
Total Current Assets	13.64M	9.21M	3M	20.48M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	392.49K	110.55K	n/a	n/a
Total Assets	14.04M	9.32M	3M	20.48M
Account Payables	1.52M	1.92M	3.42M	2.13M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	3.59M	0	277.5K	2.08M
Total Current Liabilities	5.71M	8.8M	6.92M	4.34M
Long-Term Debt	404.99K	n/a	n/a	404.99K
Other Long-Term Liabilities	n/a	411.76K	95.7M	900.76K
Total Long-Term Liabilities	404.99K	411.76K	95.7M	1.31M
Total Liabilities	6.11M	9.21M	102.62M	5.65M
Total Debt	404.99K	n/a	n/a	404.99K
Book Value	7.92M	104.19K	-99.63M	14.83M
Book Value Per Share	0.38	0.01	-6.63	0.99
Common Stock	23	20	2	3
Retained Earnings	-154.61M	-132.38M	-105.09M	-80.35M
Comprehensive Income	n/a	n/a	0	n/a
Shareholders Equity	7.92M	104.19K	-99.63M	14.83M
Total Investments	n/a	n/a	n/a	n/a